Logo image of ONWD.BR

ONWARD MEDICAL (ONWD.BR) Stock Fundamental Analysis

EBR:ONWD - Euronext Brussels - NL0015000HT4 - Common Stock - Currency: EUR

4.61  -0.1 (-2.23%)

Fundamental Rating

2

ONWD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. The financial health of ONWD is average, but there are quite some concerns on its profitability. ONWD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ONWD had negative earnings in the past year.
ONWD had a negative operating cash flow in the past year.
ONWD had negative earnings in each of the past 5 years.
In the past 5 years ONWD always reported negative operating cash flow.
ONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

The Return On Assets of ONWD (-75.02%) is worse than 87.93% of its industry peers.
ONWD has a Return On Equity of -191.58%. This is amonst the worse of the industry: ONWD underperforms 81.03% of its industry peers.
Industry RankSector Rank
ROA -75.02%
ROE -191.58%
ROIC N/A
ROA(3y)-52.82%
ROA(5y)-71.45%
ROE(3y)-101.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONWD.BR Yearly ROA, ROE, ROICONWD.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ONWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONWD.BR Yearly Profit, Operating, Gross MarginsONWD.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 -10K -20K -30K -40K -50K

More info and screens

4

2. Health

2.1 Basic Checks

ONWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ONWD remains at a similar level compared to 1 year ago.
The number of shares outstanding for ONWD has been increased compared to 5 years ago.
The debt/assets ratio for ONWD is higher compared to a year ago.
ONWD.BR Yearly Shares OutstandingONWD.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M
ONWD.BR Yearly Total Debt VS Total AssetsONWD.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ONWD has an Altman-Z score of -2.14. This is a bad value and indicates that ONWD is not financially healthy and even has some risk of bankruptcy.
ONWD has a Altman-Z score of -2.14. This is in the lower half of the industry: ONWD underperforms 79.31% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that ONWD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.91, ONWD is doing worse than 75.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z -2.14
ROIC/WACCN/A
WACC7.31%
ONWD.BR Yearly LT Debt VS Equity VS FCFONWD.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.65 indicates that ONWD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.65, ONWD belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
A Quick Ratio of 3.65 indicates that ONWD has no problem at all paying its short term obligations.
ONWD has a better Quick ratio (3.65) than 91.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.65
Quick Ratio 3.65
ONWD.BR Yearly Current Assets VS Current LiabilitesONWD.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.01% over the past year.
The Revenue for ONWD has decreased by -34.62% in the past year. This is quite bad
EPS 1Y (TTM)9.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.49%
Revenue 1Y (TTM)-34.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 2.01% on average over the next years.
ONWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 134.18% yearly.
EPS Next Y18.49%
EPS Next 2Y0.8%
EPS Next 3Y2.01%
EPS Next 5YN/A
Revenue Next Year-8.37%
Revenue Next 2Y135.09%
Revenue Next 3Y155.16%
Revenue Next 5Y134.18%

3.3 Evolution

ONWD.BR Yearly Revenue VS EstimatesONWD.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 50M 100M 150M
ONWD.BR Yearly EPS VS EstimatesONWD.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ONWD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONWD.BR Price Earnings VS Forward Price EarningsONWD.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONWD.BR Per share dataONWD.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.8%
EPS Next 3Y2.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ONWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONWARD MEDICAL

EBR:ONWD (5/30/2025, 7:00:00 PM)

4.61

-0.1 (-2.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-01 2025-04-01/amc
Earnings (Next)N/A N/A
Inst Owners28.63%
Inst Owner ChangeN/A
Ins Owners16.08%
Ins Owner ChangeN/A
Market Cap205.84M
Analysts85.45
Price Target12.9 (179.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.41%
PT rev (3m)-7.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.22
P/tB 25.05
EV/EBITDA N/A
EPS(TTM)-1.09
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0
BVpS0.41
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.02%
ROE -191.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.82%
ROA(5y)-71.45%
ROE(3y)-101.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.21%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.65
Quick Ratio 3.65
Altman-Z -2.14
F-Score3
WACC7.31%
ROIC/WACCN/A
Cap/Depr(3y)273.75%
Cap/Depr(5y)187.85%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.49%
EPS Next Y18.49%
EPS Next 2Y0.8%
EPS Next 3Y2.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-8.37%
Revenue Next 2Y135.09%
Revenue Next 3Y155.16%
Revenue Next 5Y134.18%
EBIT growth 1Y0.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.53%
EBIT Next 3Y-8.01%
EBIT Next 5YN/A
FCF growth 1Y-6.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.73%
OCF growth 3YN/A
OCF growth 5YN/A